Profile of eicosanoids in breath condensate in asthma and COPD

Journal of Breath Research

Volumn 6, Issue 2, 2012, Pages

  Fritscher, Leandro Genehr ^a,b,c,d   Post, Martin ^c,e   Rodrigues, Marcelo Tadday ^c,d   Silverman, Frances ^c,f   Balter, Mayer ^c,g   Chapman, Kenneth R ^c,d   Zamel, Noe ^c,d  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

^f Gage Occupational and Environmental Health Unit   (Canada)

^g MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

11 HYDROXYICOSATETRAENOIC ACID; 11 OXOTHROMBOXANE B2; 11,12 EPOXY 5,8,14 ICOSATRIENOIC ACID; 12 HYDROXYICOSATETRAENOIC ACID; 14,15 EPOXY 5,8,11 ICOSATRIENOIC ACID; 15 HYDROXYICOSATETRAENOIC ACID; 5 HYDROXYICOSATETRAENOIC ACID; 5,6 EPOXY 8,11,14 ICOSATRIENOIC ACID; 6 OXOPROSTAGLANDIN F1 ALPHA; 8 HYDROXYARACHIDONIC ACID; 8 ISOPROSTAGLANDIN F2 ALPHA; 8,9 EPOXYICOSATRIENOIC ACID; 9 HYDROXYICOSATETRAENOIC ACID; ARACHIDONIC ACID; AUTACOID; EPOXYICOSATRIENOIC ACID; HEPOXILINE A3; HEPOXILINE B3; HYDROXYICOSATETRAENOIC ACID; ICOSANOID; LEUKOTRIENE B4; LIPOXINE A4; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN J2; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; ASTHMA; BREATH ANALYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EXHALATION; EXHALED BREATH CONDENSATE; FEMALE; HUMAN; MALE; PNEUMONIA; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; COMPARATIVE STUDY; FOLLOW UP; METABOLISM; METHODOLOGY; MIDDLE AGED; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; ASTHMA; BIOLOGICAL MARKERS; BREATH TESTS; EICOSANOIDS; EXHALATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX;

EID: 84861469294     PISSN: 17527155     EISSN: 17527163     Source Type: Journal    
DOI: 10.1088/1752-7155/6/2/026001     Document Type: Article

References (21)

1. Horvath I et al 2005 Exhaled breath condensate: methodological recommendations and unresolved questions Eur. Respir. J. 26 523-48 (Pubitemid 41264218)
2. Bateman E D et al 2008 Global strategy for asthma management and prevention: GINA executive summary Eur. Respir. J. 31 143-78
3. Saetta M, Turato G, Maestrelli P, Mapp C E and Fabbri L M 2001 Cellular and structural bases of chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 163 1304-9 (Pubitemid 32506590)
4. Rabe K F et al 2007 Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am. J. Respir. Crit. Care Med. 176 532-55 (Pubitemid 47403272)
5. RTube http://www.respiratoryresearch.com/products 27-10-0003, Internet Communication
6. Copland I B, Reynaud D, Pace-Asciak C and Post M 2006 Mechanotransduction of stretch-induced prostanoid release by fetal lung epithelial cells Am. J. Physiol. Lung Cell. Mol. Physiol. 291 L487-95 (Pubitemid 44343726)
7. Cap P et al 2004 Gas chromatography/mass spectrometry analysis of exhaled leukotrienes in asthmatic patients Thorax 59 465-70 (Pubitemid 38797517)
8. Kielbasa B et al 2008 Eicosanoids in exhaled breath condensates in the assessment of childhood asthma Pediatr. Allergy Immunol. 19 660-9
9. Vachier I et al 2005 Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound J. Allergy Clin. Immunol. 115 55-60 (Pubitemid 40075421)
10. Hanazawa T, Kharitonov S A and Barnes P J 2000 Increased nitrotyrosine in exhaled breath condensate of patients with asthma Am. J. Respir. Crit. Care Med. 162 1273-6
11. Csoma Z, Kharitonov S A, Balint B, Bush A, Wilson N M and Barnes P J 2002 Increased leukotrienes in exhaled breath condensate in childhood asthma Am. J. Respir. Crit. Care Med. 166 1345-9 (Pubitemid 35292700)
12. Bodini A et al 2004 Exhaled breath condensate eicosanoids and sputum eosinophils in asthmatic children: a pilot study Pediatr. Allergy Immunol. 15 26-31 (Pubitemid 38327296)
13. Biernacki W A, Kharitonov S A and Barnes P J 2003 Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD Thorax 58 294-8
14. Baraldi E et al 2003 Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations Thorax 58 505-9 (Pubitemid 36714012)
15. Antczak A, Montuschi P, Kharitonov S, Gorski P and Barnes P J 2002 Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma Am. J. Respir. Crit. Care Med. 166 301-6 (Pubitemid 34864417)
16. Montuschi P, Kharitonov S A, Ciabattoni G and Barnes P J 2003 Exhaled leukotrienes and prostaglandins in COPD Thorax 58 585-8
17. Kostikas K, Papatheodorou G, Psathakis K, Panagou P and Loukides S 2003 Prostaglandin E2 in the expired breath condensate of patients with asthma Eur. Respir. J. 22 743-7 (Pubitemid 37369561)
18. Baraldi E et al 2003 Increased exhaled 8-isoprostane in childhood asthma Chest 124 25-31 (Pubitemid 36851327)
19. Montuschi P and Barnes P J 2002 Exhaled leukotrienes and prostaglandins in asthma J. Allergy Clin. Immunol. 109 615-20 (Pubitemid 34327186)
20. Zanconato S et al 2004 Leukotrienes and 8-isoprostane in exhaled breath condensate of children with stable and unstable asthma J. Allergy Clin. Immunol. 113 257-63 (Pubitemid 38210547)
21. Montuschi P, Corradi M, Ciabattoni G, Nightingale J, Kharitonov S A and Barnes P J 1999 Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients Am. J. Respir. Crit. Care Med. 160 216-20 (Pubitemid 29326091)